• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的临终患者报告结局量表的初步开发与验证,该量表用于评估患者在临终时完成身后事务的能力。

Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life.

作者信息

McCaffrey Nikki, Skuza Pawel, Breaden Katrina, Eckermann Simon, Hardy Janet, Oaten Sheila, Briffa Michael, Currow David

机构信息

Flinders Centre for Clinical Change and Health Care Research, Flinders University, Daw Park, South Australia, Australia.

2eResearch@Flinders, Central Library, Flinders University, Bedford Park, South Australia, Australia.

出版信息

PLoS One. 2014 Apr 15;9(4):e94316. doi: 10.1371/journal.pone.0094316. eCollection 2014.

DOI:10.1371/journal.pone.0094316
PMID:24736285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3988060/
Abstract

INTRODUCTION

The ability of patients to finalise their affairs at the end of life is an often neglected aspect of quality of life (QOL) measurement in palliative care effectiveness research despite compelling evidence of the high value patients place on this domain.

OBJECTIVE

This paper describes the preliminary development and evaluation of a new, single-item, end-of-life patient-reported outcome measure (EOLPRO) designed to capture changes in the ability of patients to finalise their affairs at the end of life.

METHODS

Cognitive interviews with purposively sampled Australian palliative care patients (N = 9) were analysed thematically to explore content validity. Simultaneously, secondary analysis of data from a randomised controlled trial comparing ketamine and placebo for the management of cancer pain (N = 185) evaluated: construct validity; test-retest reliability; and responsiveness.

RESULTS

Preliminary findings suggest patients interpret the new measure consistently. The EOLPRO captures the ability to complete physical tasks and finalise practical matters although it is unclear whether emotional tasks or resolution of relationship issues are considered. Personal and financial affairs should be separated to allow for differences in ability for these two types of affairs. The significant correlation between performance status and EOLPRO scores (r = 0.41, p<0.01, n = 137) and expected relationships between EOLPRO and proximity to death and constipation demonstrated construct validity. Pre- and post-treatment EOLPRO scores moderately agreed (n = 14, κ = 0.52 [95% CI 0.19, 0.84]) supporting reliability. The measure's apparent lack of sensitivity to discriminate between treatment responders and non-responders may be confounded.

CONCLUSION

Based on the preliminary findings, the EOLPRO should be separated into 'personal' and 'financial' affairs with further testing suggested, particularly to verify coverage and responsiveness. Initial evaluation suggests that the single-item EOLPRO is a useful addition to QOL outcome measurement in palliative care effectiveness research because common palliative care specific QOL questionnaires do not include or explicitly capture this domain.

摘要

引言

尽管有确凿证据表明患者非常重视临终时安排自身事务的能力,但在姑息治疗效果研究中,这一方面在生活质量(QOL)测量中常常被忽视。

目的

本文描述了一种新的、单项的、患者报告的临终结局测量指标(EOLPRO)的初步开发和评估,该指标旨在捕捉患者在临终时安排自身事务能力的变化。

方法

对有目的地抽取的澳大利亚姑息治疗患者(N = 9)进行认知访谈,并进行主题分析以探索内容效度。同时,对一项比较氯胺酮和安慰剂治疗癌症疼痛的随机对照试验的数据(N = 185)进行二次分析,评估:结构效度;重测信度;以及反应度。

结果

初步研究结果表明患者对新指标的理解一致。EOLPRO能够体现完成身体任务和处理实际事务的能力,不过尚不清楚情感任务或关系问题的解决是否也被纳入考量。个人事务和财务事务应分开,以考虑这两类事务处理能力的差异。功能状态与EOLPRO评分之间存在显著相关性(r = 0.41,p < 0.01,n = 137),且EOLPRO与接近死亡和便秘之间的预期关系证明了结构效度。治疗前后EOLPRO评分有中度一致性(n = 14,κ = 0.52 [95% CI 0.19, 0.84]),支持信度。该指标在区分治疗反应者和无反应者方面明显缺乏敏感性,这可能存在混淆因素。

结论

基于初步研究结果,EOLPRO应分为“个人”和“财务”事务,并建议进一步测试,特别是要验证涵盖范围和反应度。初步评估表明,单项EOLPRO是姑息治疗效果研究中生活质量结局测量的一个有用补充,因为常见的姑息治疗特定生活质量问卷未包括或明确涵盖这一领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5c/3988060/8a1bc910e1ed/pone.0094316.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5c/3988060/fef317a79660/pone.0094316.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5c/3988060/8a1bc910e1ed/pone.0094316.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5c/3988060/fef317a79660/pone.0094316.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff5c/3988060/8a1bc910e1ed/pone.0094316.g002.jpg

相似文献

1
Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life.一种新的临终患者报告结局量表的初步开发与验证,该量表用于评估患者在临终时完成身后事务的能力。
PLoS One. 2014 Apr 15;9(4):e94316. doi: 10.1371/journal.pone.0094316. eCollection 2014.
2
Towards patient-centred cancer care: cross-cultural validity and responsiveness of the Turkish Integrated Palliative care Outcome Scale.迈向以患者为中心的癌症护理:土耳其综合姑息治疗结局量表的跨文化有效性和反应性。
Health Qual Life Outcomes. 2020 Sep 22;18(1):312. doi: 10.1186/s12955-020-01535-5.
3
QOLLTI-F: measuring family carer quality of life.QOLLTI-F:衡量家庭照顾者的生活质量。
Palliat Med. 2006 Dec;20(8):755-67. doi: 10.1177/0269216306072764.
4
Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.蕈样肉芽肿/赛塞里综合征皮肤T细胞淋巴瘤患者生活质量的测量:一种电子仪器的开发
J Med Internet Res. 2019 Jan 7;21(1):e11302. doi: 10.2196/11302.
5
A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.慢性免疫性血小板减少性紫癜成年患者健康相关生活质量的疾病特异性测量:一项开放标签临床试验中的心理测量测试
Clin Ther. 2007 May;29(5):950-962. doi: 10.1016/j.clinthera.2007.05.005.
6
Psychometric properties of the Czech Integrated Palliative Outcome Scale: reliability and content validity analysis.捷克综合姑息治疗结局量表的心理测量学特性:信度和内容效度分析。
BMC Palliat Care. 2020 Mar 25;19(1):39. doi: 10.1186/s12904-020-00552-x.
7
The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.AMBER 关怀包用于生命末期临近、康复情况不确定的住院患者:改善关怀可行性群组 RCT。
Health Technol Assess. 2019 Oct;23(55):1-150. doi: 10.3310/hta23550.
8
Validation of the 7-item Functional Assessment of Cancer Therapy-General (FACT-G7) as a short measure of quality of life in patients with advanced cancer.验证 7 项癌症治疗功能评估一般量表(FACT-G7)作为晚期癌症患者生活质量的简短测量工具。
Cancer. 2020 Aug 15;126(16):3750-3757. doi: 10.1002/cncr.32981. Epub 2020 May 27.
9
The EORTC core quality of life questionnaire (QLQ-C30, version 3.0) in terminally ill cancer patients under palliative care: validity and reliability in a Hellenic sample.姑息治疗下晚期癌症患者的欧洲癌症研究与治疗组织核心生活质量问卷(QLQ-C30,第3.0版):希腊样本中的效度和信度
Int J Cancer. 2001 Oct 1;94(1):135-9. doi: 10.1002/ijc.1439.
10
Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.EORTC QLQ-BM22 与 FACT-BP 评估癌症骨转移患者生活质量的比较。
Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):213-9. doi: 10.1586/erp.11.99.

引用本文的文献

1
Understanding data visualization techniques in qualitative studies used to develop and validate patient-reported outcome measures: a targeted literature review.理解用于开发和验证患者报告结局指标的定性研究中的数据可视化技术:一项针对性文献综述。
Qual Life Res. 2025 Apr 25. doi: 10.1007/s11136-025-03964-5.
2
How well do the adult social care outcomes toolkit for carers, carer experience scale and care-related quality of life capture aspects of quality of life important to informal carers in Australia?照顾者成人社会关怀结果工具包、照顾者体验量表和与关怀相关的生活质量如何能捕捉到澳大利亚非正规照顾者生活质量的重要方面?
Qual Life Res. 2023 Nov;32(11):3109-3121. doi: 10.1007/s11136-023-03459-1. Epub 2023 Jun 25.
3

本文引用的文献

1
Development of a supportive care measure for economic evaluation of end-of-life care using qualitative methods.运用定性方法制定用于临终关怀经济评估的支持性护理措施。
Palliat Med. 2014 Feb;28(2):151-7. doi: 10.1177/0269216313489368. Epub 2013 May 22.
2
Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.一项随机、双盲、安慰剂对照研究,评估皮下注射氯胺酮治疗癌症疼痛的疗效和毒性。
J Clin Oncol. 2012 Oct 10;30(29):3611-7. doi: 10.1200/JCO.2012.42.1081. Epub 2012 Sep 10.
3
How should we use the visual analogue scale (VAS) in rehabilitation outcomes? I: How much of what? The seductive VAS numbers are not true measures.
Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide.
不可手术恶性肠梗阻患者的健康相关生活质量:奥曲肽双盲、平行、安慰剂对照随机试验的次要结局。
BMC Cancer. 2020 Oct 31;20(1):1050. doi: 10.1186/s12885-020-07549-y.
4
New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).亨廷顿病中捕捉临终关怀问题的新措施:意义与目的以及对HDQLIFE(一种患者报告结局测量系统)中死亡与濒死的关注
Qual Life Res. 2016 Oct;25(10):2403-2415. doi: 10.1007/s11136-016-1354-y. Epub 2016 Jul 8.
我们应如何在康复结果中使用视觉模拟量表(VAS)?I:针对什么的多少?诱人的VAS数字并非真实的测量指标。
J Rehabil Med. 2012 Sep;44(9):798-9; discussion 803-4. doi: 10.2340/16501977-1030.
4
Outcome assessment instruments in palliative and hospice care--a review of the literature.姑息治疗和临终关怀中的结局评估工具——文献回顾。
Support Care Cancer. 2012 Nov;20(11):2879-93. doi: 10.1007/s00520-012-1415-x. Epub 2012 Mar 13.
5
Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review.比较数字评分量表、语言评分量表和视觉模拟量表评估成人疼痛强度的研究:系统文献回顾。
J Pain Symptom Manage. 2011 Jun;41(6):1073-93. doi: 10.1016/j.jpainsymman.2010.08.016.
6
Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI).采用验证性因子分析评估简明疼痛量表(BPI)的结构效度。
J Pain Symptom Manage. 2011 Mar;41(3):558-65. doi: 10.1016/j.jpainsymman.2010.05.008. Epub 2010 Dec 4.
7
The association between noncancer pain, cognitive impairment, and functional disability: an analysis of the Canadian study of health and aging.非癌症疼痛、认知障碍和功能障碍之间的关联:对加拿大健康老龄化研究的分析。
J Gerontol A Biol Sci Med Sci. 2010 Aug;65(8):880-6. doi: 10.1093/gerona/glq039. Epub 2010 Mar 29.
8
Method agreement analysis: a review of correct methodology.方法学一致性分析:对正确方法学的综述。
Theriogenology. 2010 Jun;73(9):1167-79. doi: 10.1016/j.theriogenology.2010.01.003.
9
The Brief Pain Inventory and its "pain at its worst in the last 24 hours" item: clinical trial endpoint considerations.简短疼痛量表及其“过去 24 小时内最剧烈的疼痛”项目:临床试验终点的考虑因素。
Pain Med. 2010 Mar;11(3):337-46. doi: 10.1111/j.1526-4637.2009.00774.x. Epub 2010 Jan 15.
10
Reliability and validity in a nutshell.信度与效度概述。
J Clin Nurs. 2009 Dec;18(23):3237-43. doi: 10.1111/j.1365-2702.2009.02939.x.